CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PharmaRoth Labs Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PharmaRoth Labs Inc
8861 W. Sahara Ave. Suite 210
Phone: (212) 541-6222p:212 541-6222 LAS VEGAS, NV  89117  United States Ticker: ROTHROTH
This company ceased filing statements with the SEC on 12/31/2012.
Business Summary
PharmaRoth Labs, Inc. is a nutraceutical company that is focused on the prevention and treatment of healthcare diabetes. The Company is engaged in the production, marketing, and distribution of Sucanon, a clinically-tested herbal-based nutraceutical treatment for type II diabetes. Sucanon is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20116/30/2010YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
7389 Business services, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer Luis M.Lopez 7/12/2012 8/31/2010
Interim Chief Financial Officer BarryHall 1/22/2013 1/22/2013

Business Names
Business Name
Fero Industries Inc.
FERO INDUSTRIES, INC.
ROTH

General Information
Outstanding Shares: 394,014,970 (As of 4/13/2018)
Shareholders: 14
Stock Exchange: OTC
Federal Tax Id: 010884456


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023